Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death
/in Dendritic Cells, International Publications, Malignant Lymphoma /von 2010-09-30 / Cancer Res. 2010 Nov;70(22):9062-72A randomized trial of ex vivo CD40L activation of a dendritic cell vaccine in colorectal cancer patients: tumor-specific immune responses are associated with improved survival
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2010-09-30 / Clin. Cancer Res. 2010 Nov;16(22):5548-56Dendritic cells transfected with Her2 antigen-encoding RNA replicons cross-prime CD8 T cells and protect mice against tumor challenge
/in Dendritic Cells, International Publications /von 2010-09-29 / Vaccine 2010 Nov;28(49):7764-73Dendritic cell vaccine in addition to FOLFIRI regimen improve antitumor effects through the inhibition of immunosuppressive cells in murine colorectal cancer model
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2010-09-28 / Vaccine 2010 Nov;28(49):7787-96Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2010-09-27 / J Transl Med 2010 Sep;8:89Measurement and mathematical modeling of thermally induced injury and heat shock protein expression kinetics in normal and cancerous prostate cells
/in Hyperthermia, International Publications, Prostate Cancer /von 2010-09-21 / Int J Hyperthermia 2010;26(8):748-64Genetically engineered oncolytic Newcastle disease virus effectively induces sustained remission of malignant pleural mesothelioma
/in International Publications, Malignant Pleural Mesothelioma, Newcastle Disease Virus /von 2010-09-21 / Mol. Cancer Ther. 2010 Oct;9(10):2761-9Intracavity hyperthermia in nasopharyngeal cancer: a phase III clinical study
/in Hyperthermia, International Publications /von 2010-09-21 / Int J Hyperthermia 2011;27(2):180-6IFN{gamma} markedly cooperates with intratumoral dendritic cell vaccine in dog tumor models
/in Dendritic Cells, International Publications /von 2010-09-07 / Cancer Res. 2010 Sep;70(18):7093-101
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution